Cannabis effective against spasticity in MS patients, study confirms
Cannabis can reduce spasticity in multiple sclerosis (MS) patients, a study has found
A systematic review, published in the open access journal BMC Neurology, found that five out six randomised controlled trials reported a reduction in spasticity and an improvement in mobility.
Shaheen Lakhan and Marie Rowland from the Global Neuroscience Initiative Foundation, Los Angeles, USA, searched for trials evaluating the cannabis extracts deltatetrahydrocannabinol (THC) and cannabidiol (CBD). According to Lakhan, “We found evidence that combined THC and CBD extracts may provide therapeutic benefit for MS spasticity symptoms”.
Spasticity, involuntary muscle tension or contraction, is a common symptom of MS. Many existing therapies for this symptom are ineffective, difficult to obtain, or associated with intolerable side effects. In this study, reported incidence of side effects from cannabis, such as intoxication, varied greatly depending on the amount of cannabis needed to effectively limit spasticity, but the researchers note that side effects were also seen in the placebo groups. They add, “Considering the distress and limitations spasticity brings to individuals with MS, it is important to carefully weigh the potential for side effects with the potential for symptom relief “.
Lakhan concludes, “The therapeutic potential of cannabinoids in MS is comprehensive and should be given considerable attention”.
Have your say
You must sign in to make a comment.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.



Restraining someone can stop them living the life they would choose




Readers' comments (4)
Lesley Fildes | 3-Dec-2009 9:49 am
but will anybody take notice?
A sufferer
Unsuitable or offensive?
Anonymous | 3-Dec-2009 4:21 pm
There is a clinical trial currently underway called CUPID to see if one of the cannabinods (THC) is effective in slowing down the development of disability in MS. It is due to complete in 2012.
There is a cannabinoid product on the market called Sativex which I believe can be prescribed off licence.
Unsuitable or offensive?
Mary Lynn Mathre | 5-Dec-2009 11:34 pm
Cannabis is not only effective in the treatment of MS, but also for a wide variety of illnesses and symptom management. Within the past decade researchers have discovered the endocannabinoid system and it is vital to life and involved in numerous physiological processes. Nurses can learn more through the website of Patients Out of Time, a non-profit organization dedicated to educating healthcare professionals and the public about the efficacy of cannabis as medicine: www.medicalcannabis.com
Unsuitable or offensive?
Storm Crow | 8-Dec-2009 10:30 pm
Rather than scan all the medical journals for articles on the medical uses of cannabis, please run a search on "Granny Storm Crow's list- July 2009" for links to hundreds of medical studies and articles about cannabis.
Unsuitable or offensive?